191 related articles for article (PubMed ID: 38034768)
1. T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy.
Reithofer M; Boell SL; Kitzmueller C; Horak F; Bohle B; Jahn-Schmid B
Heliyon; 2023 Nov; 9(11):e21878. PubMed ID: 38034768
[TBL] [Abstract][Full Text] [Related]
2. Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy.
Heldner A; Alessandrini F; Russkamp D; Heine S; Schnautz B; Chaker A; Mwange J; Carreno Velazquez TL; Heath MD; Skinner MA; Kramer MF; Zissler UM; Schmidt-Weber CB; Blank S
Allergy; 2022 Mar; 77(3):907-919. PubMed ID: 34287971
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of T cells with grass pollen allergen extract and allergoid.
Kahler H; Stüwe H; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 1999 Oct; 120(2):146-57. PubMed ID: 10545769
[TBL] [Abstract][Full Text] [Related]
4. Chemical modification of birch allergen extract leads to a reduction in allergenicity as well as immunogenicity.
Würtzen PA; Lund L; Lund G; Holm J; Millner A; Henmar H
Int Arch Allergy Immunol; 2007; 144(4):287-95. PubMed ID: 17641548
[TBL] [Abstract][Full Text] [Related]
5. Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid.
Pfaar O; Hohlfeld JM; Al-Kadah B; Hauswald B; Homey B; Hunzelmann N; Schliemann S; Velling P; Worm M; Klimek L
Clin Exp Allergy; 2017 Nov; 47(11):1445-1455. PubMed ID: 28696503
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Intact Allergen Extracts and Allergoids For Subcutaneous Immunotherapy: The Effect of Chemical Modification Differs Both Between Species and Between Individual Allergen Molecules.
Henmar H; Nedergaard Larsen J; Lund L; Hvalsøe Meno K; Ferreras M
J Investig Allergol Clin Immunol; 2023 Jun; 33(3):190-199. PubMed ID: 35088765
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice.
Petrarca C; Clemente E; Amato V; Gatta A; Cortese S; Lamolinara A; Rossi C; Zanotta S; Mistrello G; Paganelli R; Di Gioacchino M
Clin Mol Allergy; 2016; 14():7. PubMed ID: 27499704
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Role in Childhood Mite Allergy and Allergen Immunotherapy (AIT).
Petrarca C; Viola D
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371795
[TBL] [Abstract][Full Text] [Related]
9. Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG
Eckl-Dorna J; Weber M; Stanek V; Linhart B; Ristl R; Waltl EE; Villazala-Merino S; Hummel A; Focke-Tejkl M; Froeschel R; Neubauer A; Henning R; Perkmann T; Valenta R; Niederberger V
EBioMedicine; 2019 Dec; 50():421-432. PubMed ID: 31786130
[TBL] [Abstract][Full Text] [Related]
10. Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience.
Jensen-Jarolim E; Roth-Walter F; Jordakieva G; Pali-Schöll I
J Allergy Clin Immunol Pract; 2021 May; 9(5):1780-1789. PubMed ID: 33753052
[TBL] [Abstract][Full Text] [Related]
11. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.
Larenas-Linnemann D; Rodríguez-Pérez N; Luna-Pech JA; Rodríguez-González M; Blandón-Vijil MV; Del-Río-Navarro BE; Costa-Domínguez MDC; Navarrete-Rodríguez EM; Macouzet-Sánchez C; Ortega-Martell JA; Pozo-Beltrán CF; Estrada-Cardona A; Arias-Cruz A; Rodríguez Galván KG; Brito-Díaz H; Canseco-Raymundo MDR; Castelán-Chávez EE; Escalante-Domínguez AJ; Gálvez-Romero JL; Gómez-Vera J; González-Díaz SN; Guerrero-Núñez MGB; Hernández-Colín DD; Macías-Weinmann A; Mendoza-Hernández DA; Meneses-Sánchez NA; Mogica-Martínez MD; Moncayo-Coello CV; Montiel-Herrera JM; O'Farril-Romanillos PM; Onuma-Takane E; Ortega-Cisneros M; Rangel-Garza L; Stone-Aguilar H; Torres-Lozano C; Venegas-Montoya E; Wakida-Kusunoki G; Partida-Gaytán A; López-García AI; Macías-Robles AP; Ambriz-Moreno MJ; Azamar-Jácome AA; Beltrán-De Paz CY; Caballero-López C; Fernández de Córdova-Aguirre JC; Fernández-Soto JR; Lozano-Sáenz JS; Oyoqui-Flores JJ; Osorio-Escamilla RE; Ramírez-Jiménez F; Rivero-Yeverino D; Martínez Infante E; Medina-Ávalos MA
World Allergy Organ J; 2020 Aug; 13(8):100444. PubMed ID: 32884611
[TBL] [Abstract][Full Text] [Related]
12. Allergoid-specific T-cell reaction as a measure of the immunological response to specific immunotherapy (SIT) with a Th1-adjuvanted allergy vaccine.
von Baehr V; Hermes A; von Baehr R; Scherf HP; Volk HD; Fischer von Weikersthal-Drachenberg KJ; Woroniecki S
J Investig Allergol Clin Immunol; 2005; 15(4):234-41. PubMed ID: 16433203
[TBL] [Abstract][Full Text] [Related]
13. Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy.
Eljaszewicz A; Ruchti F; Radzikowska U; Globinska A; Boonpiyathad T; Gschwend A; Morita H; Helbling A; Arasi S; Kahlert H; Berek N; Nandy A; Akdis M; Willers C; Moniuszko M; Akdis CA; Sokolowska M
J Allergy Clin Immunol; 2021 May; 147(5):1865-1877. PubMed ID: 33039478
[TBL] [Abstract][Full Text] [Related]
14. Differences in allergen-specific basophil activation and T cell proliferation in atopic dermatitis patients with comorbid allergic rhinoconjunctivitis treated with a monoclonal anti-IL-4Rα antibody or allergen-specific immunotherapy.
Layritz AS; Galicia-Carreón J; Benfadal S; Novak N
Immun Inflamm Dis; 2023 Apr; 11(4):e808. PubMed ID: 37102639
[TBL] [Abstract][Full Text] [Related]
15. Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy.
Zimmermann J; Goretzki A; Meier C; Wolfheimer S; Lin YJ; Rainer H; Krause M; Wedel S; Spies G; Führer F; Vieths S; Scheurer S; Schülke S
Front Immunol; 2022; 13():916491. PubMed ID: 36059475
[TBL] [Abstract][Full Text] [Related]
16. An exhausted phenotype of T
Wang SH; Zissler UM; Buettner M; Heine S; Heldner A; Kotz S; Pechtold L; Kau J; Plaschke M; Ullmann JT; Guerth F; Oelsner M; Alessandrini F; Blank S; Chaker AM; Schmidt-Weber CB; Jakwerth CA
Allergy; 2021 Sep; 76(9):2827-2839. PubMed ID: 33969495
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy.
Starchenka S; Heath MD; Lineberry A; Higenbottam T; Skinner MA
World Allergy Organ J; 2019 Nov; 12(11):100087. PubMed ID: 31768216
[TBL] [Abstract][Full Text] [Related]
18. The role of allergoids in allergen immunotherapy: from injective to sublingual route.
Compalati E; Incorvaia C; Cavaliere C; Masieri S; Gargiulo A; Mistrello G; Frati F
Eur Ann Allergy Clin Immunol; 2020 Sep; 52(5):195-204. PubMed ID: 32338477
[No Abstract] [Full Text] [Related]
19. Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1.
Sirvent S; Soria I; Cirauqui C; Cases B; Manzano AI; Diez-Rivero CM; Reche PA; López-Relaño J; Martínez-Naves E; Cañada FJ; Jiménez-Barbero J; Subiza J; Casanovas M; Fernández-Caldas E; Subiza JL; Palomares O
J Allergy Clin Immunol; 2016 Aug; 138(2):558-567.e11. PubMed ID: 27177779
[TBL] [Abstract][Full Text] [Related]
20. Single-cell RNA sequencing identifies precise tolerogenic cellular and molecular pathways induced by depigmented-polymerized grass pollen allergen extract.
Layhadi JA; Moya R; Tan TJ; Lenormand MM; Sharif H; Parkin RV; Vila-Nadal G; Fedina O; Zhu R; Laisuan W; Durham SR; Carnés J; Shamji MH
J Allergy Clin Immunol; 2023 May; 151(5):1357-1370.e9. PubMed ID: 36649758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
